| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/16/2008 | EP1877441A2 Method of producing human igg antibodies with enhanced effector functions |
| 01/16/2008 | EP1877439A2 Il-21 variants |
| 01/16/2008 | EP1877421A2 Single-chain antibody with cleavable linker |
| 01/16/2008 | EP1877420A1 Combination therapy in the treatment of cancer |
| 01/16/2008 | EP1877140A1 Antibody or a fragment thereof, having neutralizing activity against hiv |
| 01/16/2008 | EP1877102A2 Tab molecules |
| 01/16/2008 | EP1877083A2 Antibodies for the treatment of cancers |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1457559B1 Artificial antibody library with super-repertory |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1279039B1 Diagnostic assay involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/16/2008 | EP1255562B1 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | EP1074268B1 Preventives or remedies for inflammatory intestinal diseases containing il-6 receptor antagonist antibodies |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107360A HCV F protein and uses thereof |
| 01/16/2008 | CN101107359A A method of prime-boost vaccination |
| 01/16/2008 | CN101107269A Monoclonal antibodies against NKG2A |
| 01/16/2008 | CN101107268A Specific binding members for NGF |
| 01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 01/16/2008 | CN101104854A Antihuman telomere enzyme reverse transcriptase single-chain antibody |
| 01/16/2008 | CN101104852A Human new gene LOC344967 correlated with nasopharyngeal carcinoma and coding protein product thereof |
| 01/16/2008 | CN101104640A Preparation for anti human PD-L1 monoclonal antibody and application thereof |
| 01/16/2008 | CN101104639A Preparation for anti human B7-H3 monoclonal antibody and application thereof |
| 01/16/2008 | CN101104636A HIV peptides from gag p17 and p24 conservative region and its uses in such as vaccine |
| 01/16/2008 | CN100362018C Recombinant monoclonal antibody against EGFR |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319141 Stem cell growth factor-like polypeptides |
| 01/15/2008 | US7319140 Binding compounds to DAP12 proteins |
| 01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
| 01/15/2008 | US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 01/15/2008 | US7319135 PRO1341 polypeptides |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319034 Modifications of apoptin |
| 01/15/2008 | US7319019 Biodrug has glial cell mitogenic activity; induce central glial proliferation to induce myelination and treat multiple sclerosis |
| 01/15/2008 | US7319010 Detection and treatment of cancers of the colon |
| 01/15/2008 | US7319006 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/15/2008 | US7318926 Complex of antigen, antibodies or ligand, receptors; therapy, prevention of human diseases |
| 01/15/2008 | US7318925 Methods of use for antibodies against parathyroid hormone |
| 01/15/2008 | US7318924 Antibodies against cancer |
| 01/15/2008 | US7318923 Humanized anti-βantibodies |
| 01/15/2008 | US7318922 Anti-PRO5337 antibodies |
| 01/15/2008 | US7318921 Therapeutic compositions that alter the immune response |
| 01/15/2008 | CA2428319C Compositions and methods for diagnosing or treating psoriasis |
| 01/15/2008 | CA2289691C Methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/15/2008 | CA2195303C Method for selecting high-expressing host cells |
| 01/10/2008 | WO2008006102A2 Use of retro-aldol reaction to generate reactive vinyl ketone for attachment to anitibody molecules by michael addition reaction for use in immunostaining and immunotargeting |
| 01/10/2008 | WO2008005455A2 Peptide antibody depletion and its application to mass spectrometry sample preparation |
| 01/10/2008 | WO2008005429A2 Composition for modulating the expression of cell adhesion molecules |
| 01/10/2008 | WO2008004834A1 Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor |
| 01/10/2008 | WO2008004760A1 Antibody specifically binding to dr5 and composition for preventing or treating cancers comprising the same |
| 01/10/2008 | WO2008004536A1 Toxin detection method |
| 01/10/2008 | WO2008003931A1 Framework selection |
| 01/10/2008 | WO2008003926A1 Il-22 like protein |
| 01/10/2008 | WO2008003515A1 Small streptococcus pyogenes antigens and their use |
| 01/10/2008 | WO2008003319A1 Cd20 binding molecules for the treatment of copd |
| 01/10/2008 | WO2008003103A2 Novel multivalent immunoglobulins |
| 01/10/2008 | WO2007133290A3 Anti-ox40l antibodies and methods using same |
| 01/10/2008 | WO2007128987A3 Therapy targeting cathepsin s |
| 01/10/2008 | WO2007115814A3 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/10/2008 | WO2007109686A3 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto |
| 01/10/2008 | WO2007092640A3 Antibodies that bind par-2 |
| 01/10/2008 | WO2007074496A3 Vector for efficient selection and/or maturation of an antibody and uses thereof |
| 01/10/2008 | WO2007064919A3 Binding polypeptides with restricted diversity sequences |
| 01/10/2008 | WO2007024825A3 Immunoaffinity separation and analysis compositions and methods |
| 01/10/2008 | WO2006131952A8 Novel analgesic treatment with prolonged effect |
| 01/10/2008 | WO2006090750A8 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 01/10/2008 | WO2003091400A3 Contraceptive targets |
| 01/10/2008 | US20080009610 Diagnosis and treatment of PTP related disorders |
| 01/10/2008 | US20080009609 Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor |
| 01/10/2008 | US20080009608 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 01/10/2008 | US20080009607 a humanized or monoclonal antibody that binds to mammalian chondroitin sulfate, used for medical diagnosis, modulating tumor necrosis factor and nerve growth factors |
| 01/10/2008 | US20080009444 Biologically active complex of NR6 and cardiotrophin-like-cytokine |
| 01/10/2008 | US20080009077 antibody against a soluble fibrin, which does not react with fibrinogen but specifically recognizes a conformation-changed site newly occurred in a C-terminal region of an A alpha -chain of the soluble fibrin formed through thrombin digestion of fibrinogen; disseminated intravascular coagulation |
| 01/10/2008 | US20080009065 Genes encoding insect odorant receptors and uses thereof |
| 01/10/2008 | US20080009058 Chimeric IgE Polypeptides and Host Cells |
| 01/10/2008 | US20080009038 Methods for Enhancing Antibody Activity |
| 01/10/2008 | US20080009022 Immunization of dairy cattle with chimeric gapC protein against streptococcus infection |
| 01/10/2008 | US20080009016 Novel Monkey Gpr103 and Monkey Qrfp and Method of Evaluating Compound By Using Gpr103 |
| 01/10/2008 | US20080009014 Receptor activator of NF-kappaB |
| 01/10/2008 | US20080009004 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 01/10/2008 | US20080008723 comprising a conserved di-glucosyl -tri-heptosyl inner-core moiety ; Actinobacillus pleuropneumoniae (Ap), Mannheimia haemolytica (Mh) and Pasteurella multocida (Pm); toxoids |
| 01/10/2008 | US20080008719 Methods and compositions for the treatment of prostate cancer |
| 01/10/2008 | US20080008717 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus |
| 01/10/2008 | US20080008715 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 01/10/2008 | US20080008714 TWEAK receptor agonists as anti-angiogenic agents |
| 01/10/2008 | US20080008713 Tumor Necrosis Factor Receptor I (TNFR1); immunoglobulins; competitive binding; inhibiting signal transduction; pharmacokinetics; storage stability |
| 01/10/2008 | US20080008712 Novel Phosphorylated Sequences of the Phosphatase Cdc25B, Antibodies for Said Sequences and Use Thereof |
| 01/10/2008 | US20080008710 Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma |
| 01/10/2008 | US20080008709 Conjugation of biomolecules using Diels-Alder cycloaddition |
| 01/10/2008 | US20080008707 Denatured collagen peptides and uses thereof |
| 01/10/2008 | US20080008706 B7S1: an immune modulator |
| 01/10/2008 | US20080008703 Humanized Antibody Specific For Tumor Necrosis Factor-Alpha |
| 01/10/2008 | US20080008702 Antibody immunization therapy for treatment of atherosclerosis |
| 01/10/2008 | US20080008701 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 01/10/2008 | US20080008700 Multimeric Fc Receptor Polypeptides |
| 01/10/2008 | US20080008699 Method for proteomic analysis utilizing immune recognition and cumulative subtraction |